Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01342393 · ClinicalTrials.gov registry record
Proof of Concept Study for First-Sight Refractive Error Correction: Direct Comparison to Manifest Refraction and Autorefraction Results
A clinical trial of Refractive Error, sponsored by University of Nebraska.
- Completed
- Registry status
- 41
- Enrollment target
- 1
- Study location
NCT01342393: Completed study of Refractive Error, sponsored by University of Nebraska.
NCT01342393 is a study of Refractive Error that has completed, run by University of Nebraska. The registered enrollment target is 41 participants, below the 609-participant average among 5 other Refractive Error trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01342393, a study of Refractive Error, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- 41 participants
- Enrollment target
- 1
- Study location
Study Summary
Proof of concept study is to compare the best corrected visual acuity obtained via First-Sight lenses with the clinical "gold standard" of manifest refraction and autorefraction.
Conditions Studied
Study Locations (1)
Nebraska
- University of Nebraska Medical Center, Department of Ophthalmology - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2011-04 |
| Est. Completion | 2011-08 |
What the finished NCT01342393 record still lists
NCT01342393 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 609-participant average among 5 other Refractive Error trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Refractive Error appearing as the primary indexed condition, and to 0 interventions.
NCT01342393 reports a single indexed study location in Nebraska.
Frequently Asked Questions
What is clinical trial NCT01342393 about?
NCT01342393 is a clinical study titled "Proof of Concept Study for First-Sight Refractive Error Correction: Direct Comparison to Manifest Refraction and Autorefraction Results". Proof of concept study is to compare the best corrected visual acuity obtained via First-Sight lenses with the clinical "gold standard" of manifest refraction and autorefraction.
What is the current status of trial NCT01342393?
This trial is currently completed. The enrollment target is 41 participants. The study started on 2011-04. Estimated completion is 2011-08.
What conditions does trial NCT01342393 study?
This clinical trial studies the following conditions: Refractive Error.
Who is sponsoring clinical trial NCT01342393?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01342393 being conducted?
This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Refractive Error
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Post Marketing Clinical Study on the Efficacy of Lenses From a New Prescription Protocol
RECRUITING · NA
-
Comparative In-Vivo Wetting Characteristics of Silicone Hydrogel Materials With Selected Lens Care Systems
COMPLETED · NA
-
A Study of Interventions to Reduce Disability From Visual Loss in Nursing Home Residents
COMPLETED · Phase 4
-
A Non-Treatment Clinical Evaluation of the ELITA Single Piece Patient Interface for Docking Procedure With the ELITA
COMPLETED
-
Wavefront-guided LASIK for Monovision Treatment of Myopic Subjects With Presbyopia
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia